Clinical Trial Update: Adjuvant Whole Abdominal Intensity Modulated Radiotherapy (IMRT) for High Risk Stage FIGO III Patients With Ovarian Cancer [Phase 1]

View source ↗

Summary

This clinical trial update describes an early-phase study evaluating adjuvant whole abdominal IMRT for high-risk stage III ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Heidelberg University | Conditions: Ovarian Cancer | Phase 1 | Status: UNKNOWN